RESMED INC Operating Income Loss

• RESMED INC showed an increase of +27.7% in Operating Income Loss from 2024 to 2025.
• This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2009: $52.66 million | Q4 2009: $57.92 million | Q1 2010: $61.18 million | Q3 2010: $66.39 million | Q4 2010: $69.87 million | Q1 2011: $63.96 million | Q3 2011: $60.87 million | Q4 2011: $67.25 million | Q1 2012: $76.55 million | Q3 2012: $80.49 million | Q4 2012: $92.07 million | Q1 2013: $96.10 million | Q3 2013: $96.88 million | Q4 2013: $105.02 million | Q1 2014: $104.70 million | Q3 2014: $94.68 million | Q4 2014: $109.15 million | Q1 2015: $105.87 million | Q3 2015: $98.03 million | Q4 2015: $107.98 million | Q1 2016: $104.31 million | Q3 2016: $94.15 million | Q4 2016: $96.90 million | Q1 2017: $107.40 million | Q3 2017: $112.56 million | Q4 2017: $146.02 million | Q1 2018: $136.37 million | Q3 2018: $144.13 million | Q4 2018: $157.08 million | Q1 2019: $156.98 million | Q3 2019: $171.10 million | Q4 2019: $197.81 million | Q1 2020: $217.50 million | Q3 2020: $216.90 million | Q4 2020: $221.72 million | Q1 2021: $223.43 million | Q3 2021: $261.91 million | Q4 2021: $248.71 million | Q1 2022: $234.27 million | Q3 2022: $275.74 million | Q4 2022: $280.19 million | Q1 2023: $300.67 million | Q3 2023: $289.00 million | Q4 2023: $275.09 million | Q1 2024: $374.58 million | Q3 2024: $387.31 million | Q4 2024: $417.24 million | Q1 2025: $426.27 million | Q3 2025: $446.54 million | Q4 2025: $491.66 million.
• Over the full 17 years of available data (2009 to 2025), RESMED INC's Operating Income Loss has grown by 785.6%.
• Historical annual values: Fiscal year 2025: $1.69 billion | Fiscal year 2024: $1.32 billion | Fiscal year 2023: $1.13 billion | Fiscal year 2022: $1.00 billion | Fiscal year 2021: $903.68 million | Fiscal year 2020: $809.66 million | Fiscal year 2019: $579.26 million | Fiscal year 2018: $541.83 million | Fiscal year 2017: $425.80 million | Fiscal year 2016: $428.95 million | Fiscal year 2015: $409.24 million | Fiscal year 2014: $405.09 million | Fiscal year 2013: $354.82 million | Fiscal year 2012: $294.41 million | Fiscal year 2011: $266.92 million | Fiscal year 2010: $240.38 million | Fiscal year 2009: $190.31 million.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026